Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Venture capital funding for companies in CAR-T programs 2011-2016

This statistic shows the venture capital funding for select companies involved in CAR-T programs between 2011 and 2016. Kite Pharma had a venture capital funding of 15 million U.S. dollars in March 2011.

Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

United States

Survey time period

2011 to 2016

Supplementary notes

* CAR-T = chimeric antigen receptor T-cell.
Includes only venture capital funding for companies involved in CAR-T program(s) at the time of investment.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cell and gene therapy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.